| The Company |
 |
 |
 |
|
Overview
Konan Medical USA, Inc. is the market leader in specular microscopy. The Company was incorporated in 2008 and has its corporate headquarters in Irvine, California. The Company's parent company, Konan Medical Inc. (Japan), was established more than fifty years ago, has been in the specular microscope business since 1979 and holds over 1,600 patents. Konan has a significant majority share of the healthy and growing market for devices used to image the corneal endothelium.
Focus Cell loss in the endothelium is a strong indication that the cornea is not receiving proper nourishment. It is critical to know this for all patients who undergo corneal refractive surgery such as LASIK, PRK, corneal inlays, intraocular lenses used with cataract surgery, phakic IOLs, and various keratoconus treatments. The FDA requires that many companies developing investigational ophthalmic refractive devices routinely examine the corneal endothelium using a specular microscope. Our equipment is recognized by eyecare practitioners, regulatory groups, professional reading centers, and clinical trial experts as the gold standard for endothelial cell density analysis.
This market is driven by one of the highest Medicare reimbursement rates for a diagnostic eye care device, combined with new procedures that necessitate an evaluation of corneal health. The technology is easy to use and provides both optometrists and ophthalmologists with essential information for procedures including DSAEK, contact lens fitting, corneal transplants, refractive IOLs and many others.
Market Position Konan Medical USA, Inc. has created a sales and distribution channel covering the USA, Canada, Europe, and Latin America comprised of selected sales representatives and distributors with extensive eye care experience. Today there are over 8,000 Konan systems in use in 60 countries worldwide including almost 1,000 of the finest eye care providers in the USA using Konan clinical specular microscopes. Konan continues to earn it's predominant position in the marketplace with core strengths in clinical evidence, web-enabled customer support, expert service, and leading technologies. Konan additionally is the market leader in the eye bank specular microscopy segment.
Business Development & Investment Konan Medical USA, Inc. actively seeks promising new technologies & products to complement its existing product line and leverage the capabilities of its extensive distribution network. To explore opportunities for cooperation, please contact Charles Wm. Stewart, OD at This e-mail address is being protected from spambots. You need JavaScript enabled to view it or Dale Sadlik at This e-mail address is being protected from spambots. You need JavaScript enabled to view it . |
